SBC Medical will release fiscal year 2025 financial results on March 27, 2026, followed by a conference call.
Quiver AI Summary
SBC Medical Group Holdings Incorporated announced that it will release its financial results for the fourth quarter and fiscal year ending December 31, 2025, on March 27, 2026, before U.S. market opens. Following the release, management will host a conference call at 8:30 a.m. Eastern Time to discuss the results and operational highlights, with a Q&A session for analysts and investors. SBC Medical, which operates various franchise businesses in multiple medical fields, was listed on Nasdaq in September 2024 and was included in the Russell 3000 Index in June 2025. The company aims to improve global healthcare through innovation and offers a variety of medical services while expanding its operations in the U.S. and Asia.
Potential Positives
- Announcement of fourth quarter and fiscal year financial results release on March 27, 2026, providing transparency and informing stakeholders of the company's performance.
- Hosting of a conference call for detailed discussion on financial performance and operational highlights, fostering engagement with analysts and investors.
- Company's continued expansion in the medical sector, highlighting its diverse portfolio and global presence, which may attract investor interest.
- Inclusion in the Russell 3000® Index, enhancing credibility and visibility in the market, potentially appealing to a broader range of investors.
Potential Negatives
- The reliance on forward-looking statements may create uncertainty regarding the Company's actual future performance, potentially leading to disappointment among investors.
- The lack of immediate financial performance details in the press release could raise concerns among stakeholders about the Company's current operational efficiency and profitability.
- The company does not provide specific metrics or results leading into the earnings call, which may leave investors anxious about what to expect and could impact investor confidence.
FAQ
When will SBC Medical release its financial results?
SBC Medical will release its financial results on March 27, 2026, before U.S. market open.
How can I participate in the earnings conference call?
You can participate in the earnings conference call by registering in advance using the provided link.
What topics will be discussed during the conference call?
The conference call will cover financial performance, operational highlights, and key priorities for 2026.
Where can I access the earnings release and presentation slides?
The earnings release and accompanying slides will be available on the Company’s Investor Relations website.
What medical fields does SBC Medical operate in?
SBC Medical operates in diverse fields including aesthetics, dermatology, orthopedics, fertility, gynecology, dentistry, and ophthalmology.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SBC Insider Trading Activity
$SBC insiders have traded $SBC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $SBC stock by insiders over the last 6 months:
- YOSHIYUKI AIKAWA (Chairman and CEO) sold 4,422,900 shares for an estimated $9,376,548
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SBC Revenue
$SBC had revenues of $43.4M in Q3 2025. This is a decrease of -18.33% from the same period in the prior year.
You can track SBC financials on Quiver Quantitative's SBC stock page.
$SBC Hedge Fund Activity
We have seen 28 institutional investors add shares of $SBC stock to their portfolio, and 19 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 188,482 shares (+232.4%) to their portfolio in Q4 2025, for an estimated $812,357
- BLACKROCK, INC. added 154,791 shares (+57.0%) to their portfolio in Q4 2025, for an estimated $667,149
- GEODE CAPITAL MANAGEMENT, LLC added 71,664 shares (+37.6%) to their portfolio in Q4 2025, for an estimated $308,871
- MILLENNIUM MANAGEMENT LLC removed 50,461 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $217,486
- CITADEL ADVISORS LLC removed 29,366 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $127,448
- NORTHERN TRUST CORP added 22,431 shares (+38.1%) to their portfolio in Q4 2025, for an estimated $96,677
- WILLIAMS & NOVAK, LLC added 15,180 shares (+inf%) to their portfolio in Q4 2025, for an estimated $65,425
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. market open on March 27, 2026.
Management will host an earnings conference call on March 27, 2026, at 8:30 a.m. Eastern Time to discuss the Company’s financial performance, operational highlights, and key priorities for 2026. A question‑and‑answer session with analysts and investors will follow the prepared remarks.
Please register in advance for the conference using the link provided below.
https://zoom.us/webinar/register/WN_d1mfdSBSThST4BIiID88aQ
Additionally, the earnings release, accompanying slides, and an archived webcast of this conference call will be available at the Company’s Investor Relations website at https://ir.sbc-holdings.com/
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit
https://sbc-holdings.com
For more insights and updates from SBC Holdings, follow us on
LinkedIn
.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at
www.sec.gov
.
Contacts
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of IR Department; E-mail:
[email protected]
ICR LLC (US Time)
Bill Zima / Managing Partner; E-mail:
[email protected]